Gibbs Michael Terrence 4/A

4/A · T2 Biosystems, Inc. · Filed Mar 28, 2022

Form 4/AAmended

Period: 2022-02-20

General Counsel

Transactions

Tax Payment
Common Stock
2022-02-21$0.47/sh−5,275$2,458→ 79,923 total
Exercise/Conversion
Common Stock
2022-02-21+10,000→ 85,198 total
Award
Restricted Stock Units
2022-02-20+600,000→ 600,000 total
→ Common Stock (600,000 underlying)
Exercise/Conversion
Restricted Stock Units
2022-02-21−10,000→ 0 total
→ Common Stock (10,000 underlying)

Footnotes (7)

[F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
[F2]Includes 1,942 shares acquired under the Issuer's employee stock purchase plan ("ESPP") on May 15, 2021.
[F3]The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 75,198
[F4]5,275 shares of common stock were automatically withheld at vesting to cover required tax withholding.
[F5]The Form 4, as originally filed, incorrectly reported the amount of beneficially owned securities as 69,923
[F6]On February 20, 2022 the reporting person was granted 600,000 RSU's that vest in three equal annual installments commencing on February 20, 2023.
[F7]On February 21, 2019 the reporting person was granted 30,000 RSU's that vest in three equal annual installments beginning on February 21, 2020.

Documents

1 file